This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.68% per year. These returns cover a period from January 1, 1988 through August 5, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Consumer Staples Stock Earnings for May 1: CL, CLX & EL
by Rajani Lohia
Despite the havoc created by the Coronavirus pandemic, consumer staples companies look poised for gains from spiked demand for everyday essentials.
Why Earnings Season Could Be Great for Clorox (CLX)
by Zacks Equity Research
Clorox (CLX) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
5 Must-Buy Consumer Staples Stocks Ahead of Earnings Results
by Nalak Das
The consumer staples sector has so far reported strong results and are likely to maintain the momentum for the rest of this earnings season.
Cleaning Product Demand to Aid Clorox's (CLX) Q3 Earnings
by Zacks Equity Research
Clorox (CLX) is expected to have been the prime beneficiary of the panic buying of everyday essentials in early March, which should get reflected in its top-line results in third-quarter fiscal 2020.
Helen of Troy (HELE) Stock Up as Q4 Earnings & Sales Rise Y/Y
by Zacks Equity Research
Helen of Troy's (HELE) Q4 results benefit from increased demand for certain products along with double-digit growth in all three business segments
3 Reasons Growth Investors Will Love Clorox (CLX)
by Zacks Equity Research
Clorox (CLX) possesses solid growth attributes, which could help it handily outperform the market.
Clorox (CLX) to Report Q3 Earnings: What's in the Offing?
by Zacks Equity Research
Clorox's (CLX) third-quarter fiscal 2020 results are expected to reflect gains from the increase in demand for disinfecting wipes and floor cleaners due to the coronavirus outbreak.
Clorox (CLX) Reports Next Week: Wall Street Expects Earnings Growth
by Zacks Equity Research
Clorox (CLX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
The Zacks Analyst Blog Highlights: Clorox, Manning & Napier, Virtu Financial, PLDT and The Scotts Miracle-Gro
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Clorox, Manning & Napier, Virtu Financial, PLDT and The Scotts Miracle-Gro
3 Momentum Anomaly Stocks in Focus Amid Coronavirus Turmoil
by Zacks Equity Research
These fast movers are currently witnessing a short-term pullback in price as COVID-19 rattles market participants. So, this could possibly be a great entry point for reaping better returns.
Retirees Should Know These 3 Facts About Required Minimum Distributions - April 23, 2020
by Zacks Equity Research
Like many investors, you're likely aiming to build a comfortable nest egg to ensure a comfortable retirement. Make sure you know all about what financial planners dub the accumulation and distribution phases of retirement planning.
How Clorox (CLX) Stock Stands Out in a Strong Industry
by Zacks Equity Research
Clorox (CLX) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.
Coronavirus Ravages US Employment Boom: 5 Safe Stocks to Buy
by Sreoshi Bera
Surge in jobless claims for four consecutive weeks calls for investment in these five recession-proof stocks.
Clorox (CLX) Gains But Lags Market: What You Should Know
by Zacks Equity Research
In the latest trading session, Clorox (CLX) closed at $191.67, marking a +0.47% move from the previous day.
Is The Clorox (CLX) Stock Outpacing Its Consumer Staples Peers This Year?
by Zacks Equity Research
Is (CLX) Outperforming Other Consumer Staples Stocks This Year?
Kimberly-Clark (KMB) Q1 Earnings Top Estimates, Sales up
by Zacks Equity Research
Kimberly-Clark (KMB) generates robust cost savings in first-quarter 2020. However, management withdraws its 2020 guidance due to coronavirus outbreak.
What's in the Cards for Keurig Dr Pepper's (KDP) Q1 Earnings?
by Zacks Equity Research
Keurig Dr Pepper's (KDP) first-quarter 2020 performance is likely to reflect gains from innovation and marketing of key brands. However, growth investments are likely to entail high costs.
5 Top High-Yielding Stocks With Double-Digit Returns YTD
by Nalak Das
A closer look into Wall Street will give us a number of good stocks that have offered double-digit returns so far this year.
3 Stocks on the Rise During the Coronavirus
by James Giaquinto
3 Stocks on the Rise During the Coronavirus
Clorox (CLX) Stock Moves -0.89%: What You Should Know
by Zacks Equity Research
Clorox (CLX) closed at $190.71 in the latest trading session, marking a -0.89% move from the prior day.
Hershey (HSY) to Report Q1 Earnings: Key Factors to Note
by Zacks Equity Research
Benefits from innovation and acquisitions are likely to get reflected in Hershey's (HSY) first-quarter 2020 performance. Also, focus on efficient pricing strategies bodes well.
Coca-Cola (KO) Q1 Earnings & Revenues Surpass Estimates
by Zacks Equity Research
Coca-Cola (KO) reports robust first-quarter 2020 results, driven by strong performance in North America and Latin America through February, offset by declines in China due to the coronavirus outbreak.
Things to Note Ahead of Kimberly-Clark's (KMB) Q1 Earnings
by Zacks Equity Research
Increased demand owing to panic-buying trends amid the coronavirus outbreak is likely to get reflected in Kimberly-Clark's (KMB) first-quarter 2020 performance.
What's in the Offing for Boston Beer (SAM) in Q1 Earnings?
by Zacks Equity Research
Boston Beer's (SAM) first-quarter 2020 results are likely to reflect gains from increased depletions and shipments. However, the effects of the virus outbreak might have impacted its performance.
Procter & Gamble (PG) Q3 Earnings Beat Estimates, Sales Up
by Zacks Equity Research
Procter & Gamble's (PG) bottom line beats estimates in third-quarter fiscal 2020, while sales meet the same. Free cash flow productivity increases to 113%.